Aldo Venuti

20PUBLICATIONS
48CO-AUTHORS
Socio-economic developmentCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSocial determinants of healthBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 28, 2026
Development and Immunogenicity Assessment of a Multi-Epitope Antigen Against Zika Virus: An In Silico and In Vivo Approach.

Lígia Rosa Sales Leal, Matheus Gardini Amâncio Marques de Sena, Maria da Conceição Viana Invenção

|Aug 21, 2025
HPV E5 Mediates Resistance to Chemotherapy and Radiation by Promoting a Stem Cell-Like Phenotype in Head and Neck Squamous Cell Carcinoma.

Souvick Roy, Sayuri Miyauchi, Riley N Jones

|Apr 26, 2025
E5 Oncoprotein: A Key Player in Human Papillomavirus-Positive Head and Neck Cancer Pathogenesis and Therapy Resistance.

Vanessa Emanuelle Pereira Santos, Bianca de França São Marcos, Pedro Henrique Bezerra Fontes

|May 28, 2022
Vaccines against Infectious Diseases and Cancer.

Ângela Sousa, Christiane P Soares, Aldo Venuti

|Mar 10, 2022
Natural Bioactives: Back to the Future in the Fight against Human Papillomavirus? A Narrative Review.

Silvia Massa, Riccardo Pagliarello, Francesca Paolini

|Oct 26, 2021
Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers.

Flaminia Campo, Aldo Venuti, Fulvia Pimpinelli

Pageof 4

Frequent Collaborators

4 joint publications

Gennaro Ciliberto

3 joint publications

Antonio Carlos de Freitas

3 joint publications

Francesca Paolini

3 joint publications

Raul Pellini